Methergin

Methylergometrine Maleate, the active ingredient in Methergin, is an ergot alkaloid presented as a sterile injectable solution for intramuscular, intravenous use. It is used to prevent and treat postpartum hemorrhage and to induce labor in obstetric patients.

GNH USA supplies Methergin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres, oncology centres and clinics worldwide. Our global distribution network ensures timely delivery and regulatory compliance across Europe, Asia, Africa and the Americas. We adhere to stringent quality standards and provide comprehensive product documentation for each shipment.

Methergin (methylergometrine maleate) is a uterotonic agent used in obstetric care to promote uterine contraction.

- Prevention and treatment of postpartum hemorrhage: reduces uterine bleeding after delivery. - Induction of labor: facilitates cervical dilation and uterine contractions. - Control of postpartum uterine bleeding: assists in achieving hemostasis after childbirth.

Methylergometrine maleate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset, often transient. - Vomiting: occasional emesis that resolves spontaneously. - Headache: transient cranial discomfort. - Hypertension: temporary increase in blood pressure. - Flushing: skin redness and warmth. - Abdominal pain: mild cramping in the lower abdomen.

Serious or Rare Side Effects: - Vasospasm: severe peripheral or coronary artery constriction. - Pulmonary edema: fluid accumulation in the lungs. - Myocardial ischemia: reduced blood flow to the heart muscle. - Seizures: convulsive episodes. - Severe hypertension: hypertensive crisis requiring urgent care. - Allergic reactions: anaphylaxis or severe skin rash.

When using methylergometrine maleate, clinicians should observe several precautions to minimize risk.

- Assess cardiovascular status: evaluate blood pressure and history of hypertension before administration. - Monitor for signs of vasospasm: watch for chest pain, limb ischemia, or sudden hypertension. - Use with caution in patients with pre‑eclampsia: risk of exacerbating hypertension. - Avoid concurrent use with potent vasoconstrictors: may increase risk of severe vascular events. - Adjust dose in renal impairment: consider reduced clearance in severe kidney disease. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Methylergometrine maleate can interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Ergotamine derivatives: additive vasoconstrictive effects may cause severe ischemia. - Monoamine oxidase inhibitors (MAOIs): increased serotonergic activity can lead to hypertension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt the hypertensive response. - Calcium channel blockers: potential additive cardiovascular effects. - Antihypertensive agents: may require dose adjustment due to blood pressure changes. - Antidepressants affecting serotonin: monitor for serotonin syndrome signs.